Oral solid dosage sales will strengthen through 2035, anchored by immediate release formulations at 51.3% share of the drug release mechanism segment in 2025. Tablets account for 42.7% share of the dosage form segment in 2025. The market was valued at USD 652.9 billion in 2025 and is projected to touch USD 938.9 billion.